Growth Hormone Peptide
CJC-1295 No DAC / Ipamorelin Blend is a multi-peptide formulation developed for advanced investigation into growth hormone secretagogue activity, hypothalamic-pituitary axis signaling, and pulsatile GH release modulation.
Growth Hormone Peptide
CJC-1295 (No DAC) / Ipamorelin
CJC-1295 No DAC / Ipamorelin Blend is a multi-peptide formulation developed for advanced investigation into growth hormone secretagogue activity, hypothalamic-pituitary axis signaling, and pulsatile GH release modulatio…
1
$59.99
Most Popular
Best Value
Est. delivery Jun 4 - Jun 8
Free shipment protection
Secure checkout
We accept:
Free shipping
on orders over $200
Damage protection
on every order
Secure checkout
256-bit SSL
Certificate of Analysis
Tested for Identification, Purity, Mass, Endotoxins, Sterility, and Heavy Metals
LATEST
SELECTED DOSAGE
99.50%
PURITY
Variant
CJC-1295 (No DAC) / Ipamorelin 10MG
Lot #
CJCIPA-2605-A02
Labeled
10mg
Actual
10.11mg
Tested
May 10, 2026
Compound Information
Pharmaceutical Specifications
Molecular Profile
What Is CJC-1295 (No DAC) / Ipamorelin?
TypeSynthetic peptide blend
CAS Number863288-34-0 / 170851-70-4
Molecular FormulaC₁₄₉H₂₄₆N₄₄O₄₂S / C₃₈H₄₉N₉O₅
Molecular Weight3,367.97 / 711.87 g/mol
Amino Acids30 / 5
Storage Requirements
Stability Information
Lyophilized (powder)
-20°C · -20°C
Reconstituted
2-8°C · ~30 days
Research
Sources & References
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ENDOCRINE SOCIETY/OXFORD)
Prolonged Stimulation of Growth Hormone and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults
View Source
ENDOCRINOLOGY (ENDOCRINE SOCIETY/OXFORD)
Human GRF(1-29)-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog
View Source
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ENDOCRINE SOCIETY/OXFORD)
Pulsatile Secretion of Growth Hormone Persists During Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog
View Source
EUROPEAN JOURNAL OF ENDOCRINOLOGY (BIOSCIENTIFICA/ESE)
Ipamorelin, the First Selective Growth Hormone Secretagogue
View Source
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (SPRINGER)
Prospective, Randomized, Controlled, Proof-of-Concept Study of the Ghrelin Mimetic Ipamorelin for the Management of Postoperative Ileus in Bowel Resection Patients
View Source
EUROPEAN JOURNAL OF ENDOCRINOLOGY (BIOSCIENTIFICA/ESE)
The GH Secretagogues Ipamorelin and GH-Releasing Peptide-6 Increase Bone Mineral Content in Adult Female Rats
View Source
TRANSLATIONAL ANDROLOGY AND UROLOGY (AME PUBLISHING)
Beyond the Androgen Receptor: The Role of Growth Hormone Secretagogues in the Modern Management of Body Composition in Hypogonadal Males
View Source
ANNALS OF INTERNAL MEDICINE (ACP)
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial
View Source
SEXUAL MEDICINE REVIEWS (ELSEVIER)
The Safety and Efficacy of Growth Hormone Secretagogues
View Source
JCSM RAPID COMMUNICATIONS (WILEY)
Growth Hormone Secretagogues: History, Mechanism of Action, and Clinical Development
View Source
